Back to Search
Start Over
Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
- Source :
-
Ecancermedicalscience [Ecancermedicalscience] 2020 Apr 03; Vol. 14, pp. ed98. Date of Electronic Publication: 2020 Apr 03 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- There have been several reports noting anosmia and ageusia as possible symptoms of COVID-19. This is of particular interest in oncology since patients receiving some cancer treatments such as chemotherapy or immune therapy often experience similar symptoms as side-effects. The purpose of this report was to summarise the evidence on the existence of anosmia and ageusia an emerging COVID-19 symptoms in order to better inform both oncology patients and clinicians. Currently, there is no published evidence or case reports noting anosmia or ageusia as symptoms of COVID-19. Nevertheless, experts in rhinology have suggested that the onset of such symptoms could either act as a trigger for testing for the disease where possible, or could be a new criterion to self-isolate. Whilst more data is currently needed to strengthen our knowledge of the symptoms of COVID-19, oncology patients who are concerned about anosmia or ageusia in the context of their systemic anti-cancer therapy should contact their acute oncology support line for advice.<br />Competing Interests: None to be declared.<br /> (© the authors; licensee ecancermedicalscience.)
Details
- Language :
- English
- ISSN :
- 1754-6605
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Ecancermedicalscience
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32269598
- Full Text :
- https://doi.org/10.3332/ecancer.2020.ed98